ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,999, issued on July 7, was assigned to Roche Diagnostics Operations Inc. (Indianapolis).

"Anti-CSF-IR antibody" was invented by David Casagolda Vallribera (Penzberg, Germany), Michael Gerg (Penzberg, Germany) and Michael Schraeml (Penzberg, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a monoclonal antibody, or fragment thereof, which binds to CSF-1R (Colony stimulating factor 1 receptor), in particular to human CSF-1R. The present invention further relates to the in vitro use of the monoclonal antibody, or fragment thereof, of the present invention for the detection of CSF-1R in a sample. Further encompassed...